Coronary arterial fistulas
disease diseaseOn this page
Also known as Coronaro-cardiac fistulacoronary arterial malformations
Summary
Coronary arterial fistulas (MONDO:0016081) is a disease. A subtype of coronary artery congenital malformation — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: Unknown (Worldwide)
- Phenotypes (HPO): 27
Clinical features
Signs & symptoms
Clinical features (HPO)
27 HPO clinical features (Orphanet curated; top 27 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0001635 | Congestive heart failure | Frequent (30-79%) |
| HP:0001640 | Cardiomegaly | Frequent (30-79%) |
| HP:0001649 | Tachycardia | Frequent (30-79%) |
| HP:0002875 | Exertional dyspnea | Frequent (30-79%) |
| HP:0003115 | Abnormal EKG | Frequent (30-79%) |
| HP:0005162 | Abnormal left ventricular function | Frequent (30-79%) |
| HP:0031664 | Systolic heart murmur | Frequent (30-79%) |
| HP:0031670 | Continuous heart murmur | Frequent (30-79%) |
| HP:0001279 | Syncope | Occasional (5-29%) |
| HP:0001627 | Abnormal heart morphology | Occasional (5-29%) |
| HP:0001631 | Atrial septal defect | Occasional (5-29%) |
| HP:0001643 | Patent ductus arteriosus | Occasional (5-29%) |
| HP:0001647 | Bicuspid aortic valve | Occasional (5-29%) |
| HP:0001650 | Aortic valve stenosis | Occasional (5-29%) |
| HP:0001655 | Patent foramen ovale | Occasional (5-29%) |
| HP:0001681 | Angina pectoris | Occasional (5-29%) |
| HP:0001962 | Palpitations | Occasional (5-29%) |
| HP:0002092 | Pulmonary arterial hypertension | Occasional (5-29%) |
| HP:0002617 | Dilatation | Occasional (5-29%) |
| HP:0002789 | Tachypnea | Occasional (5-29%) |
| HP:0005133 | Right ventricular dilatation | Occasional (5-29%) |
| HP:0006689 | Bacterial endocarditis | Occasional (5-29%) |
| HP:0010741 | Pedal edema | Occasional (5-29%) |
| HP:0011675 | Arrhythmia | Occasional (5-29%) |
| HP:0012764 | Orthopnea | Occasional (5-29%) |
| HP:0030848 | Elevated jugular venous pressure | Occasional (5-29%) |
| HP:0030882 | Coronary artery aneurysm | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | coronary arterial fistulas |
| Mondo ID | MONDO:0016081 |
| Orphanet | 2041 |
| UMLS | C0265898 |
| MedGen | 488822 |
| GARD | 0001533 |
| MedDRA | 10069441 |
| Is cancer (heuristic) | no |
Also known as: Coronaro-cardiac fistula · coronary arterial malformations
Disease family
This is a subtype of coronary artery congenital malformation. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › vascular disorder › arterial disorder › coronary artery disorder › coronary artery congenital malformation › coronary arterial fistulas
Related subtypes (8): anomalous left coronary artery from the pulmonary artery, congenital coronary artery aneurysm, coronary artery intramyocardial course, aortopulmonary coronary arterial course, stenosis or atrophy of the coronary ostium, intramural coronary arterial course, abnormal number of coronary ostia, malposition of the coronary ostium
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.